patented drugs

1:48PM
Printer-friendly version
Pandemic showed that Canada needs a thriving biopharmaceutical industry

Government policies and regulations have created an environment hostile to research and innovation.


12:02PM
Printer-friendly version
Proposed ‘drug price’ changes threaten access for Canadian patients

Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.


7:40PM
Printer-friendly version
Ottawa’s changes to drug-pricing will deny some Canadians potentially lifesaving drugs

Forcing manufacturers of high-cost drugs to reduce their prices by up to 80 per cent is unsustainable.


1:56PM
Printer-friendly version

Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.


2:36PM
Printer-friendly version
The opposition of the two U.S. presidential candidates to the Trans-Pacific Partnership (TPP) threatens progress on trade issues including intellectual property protection.